ALKERMES | Kundefordringer

Trade Debtors Endring Dato
AbbVie USD 11.95B 537M 2024-03
Acadia Pharmaceuticals USD 100.08M 2.27M 2024-03
ALKERMES USD 317.08M 16.11M 2024-03
Amgen USD 6.78B 492M 2024-03
Biogen USD 2B 100.3M 2024-03
BioMarin Pharmaceutical USD 637.16M 3.46M 2024-03
Bristol-Myers Squibb USD 14.06B 1.59B 2024-03
Eli Lilly USD 10.01B 350.3M 2024-03
Gilead Sciences USD 4.67B 9M 2024-03
Intra Cellular Therapies USD 131.16M 17.14M 2024-03
Ionis Pharmaceuticals USD 5.14M 92.64M 2024-03
J&J USD 14.95B 148M 2024-03
Malin Corporation EUR 1.1M 100K 2023-06
Merck USD 11.37B 119M 2024-03
Neurocrine Biosciences USD 450.7M 32.9M 2024-03
Pfizer USD 15.22B 219M 2024-03
Regeneron Pharmaceuticals USD 5.22B 445.1M 2024-03
Vertex Pharmaceuticals USD 1.79B 254.5M 2024-03



ALKERMES Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.